Conservative treatment for patent ductus arteriosus in the preterm
- 24 January 2007
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood: Fetal & Neonatal
- Vol. 92 (4), F244-F247
- https://doi.org/10.1136/adc.2006.104596
Abstract
A patent ductus arteriosus (PDA) is common among preterms, and prophylactic medical treatment has been advocated as the first-line approach. Conservative treatment may result in similar outcome, but without exposure to the harmful side effects of medication. A retrospective analysis revealed a ductal closure rate of 94% after conservative treatment with adjustment of ventilation (lowering the inspiratory time and increasing positive end expiratory pressure) and fluid restriction. To study prospectively over one year the rate of PDA closure, and morbidity and mortality following conservative treatment. Prospective study (1 January 2005 - 31 December 2005) including 30 newborns <or=30 weeks' gestation, all of whom were being ventilated and required surfactant. Echocardiography was performed 48-72 h after birth. Clinically important PDA was conservatively treated as described above. The percentage of children with PDA, ductal ligation and major complications was determined. Ten neonates (33%) developed a clinical important PDA. Following conservative treatment the duct closed in all neonates (100%), and none required ductal ligation or medical treatment. The rates of major complications were no higher than those reported by the Vermont Oxford Network and in the literature. The managed care plan resulted in an overall ductal closure rate of 100%. These results suggest that conservative treatment of PDA is a worthy alternative to prophylactic medical treatment.Keywords
This publication has 24 references indexed in Scilit:
- Primum non nocere: prophylactic versus curative ibuprofenThe Lancet, 2004
- Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infantsPublished by Wiley ,2003
- Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infantsPublished by Wiley ,2003
- Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infantsPublished by Wiley ,2003
- Ibuprofen: alternative treatment for patent ductus arteriosus.2003
- Indomethacin for asymptomatic patent ductus arteriosus in preterm infantsCochrane Database of Systematic Reviews, 2003
- Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infantsPublished by Wiley ,2002
- Patent ductus arteriosus in very low birthweight infants: complications of pharmacological and surgical treatmentjpme, 2001
- Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosusThe Journal of Pediatrics, 1997
- Early Ibuprofen Administration to Prevent Patent Ductus Arteriosus in Premature Newborn InfantsJAMA, 1996